Soo Bang is Vice President, Enterprise Integration Management Office at BMS, leading Celgene integration across key milestones, strategic planning of markets and integration activities. Previously at Celgene, Soo was VP of Business Strategy, Integration & Planning for the Global Pharmaceutical Development & Operations. Soo has overall responsibility for the project management, operational excellence, EHS, technical commercialization and alliance management teams.
While at Celgene, Soo served the role of Executive Director, Business Development & Global Alliances, where she managed alliance relationships across Hem/Onc, I&I and Early Development, and was the business development and alliance lead for numerous collaborations with clinical programs in both biologics and small molecules, including a late-stage oncology asset acquisition and program transitions. Prior to the BD role, she was the Global Head of Clinical Site Contracts, where she led a global team responsible for study start-up activities. Before Celgene, Soo served as the Global Investigator Lead at Pfizer, responsible for contract and outsourcing across all Pfizer business units, development operations’ functional service providers, and medical affairs. She also held various leadership positions at NYC Health & Hospitals Corp, Director of Clinical Trials at NYU Medical Center, and Winthrop University Health System.
Soo also served as industry lead for the “Advancing the use of Central IRBs” for the Clinical Trials Transformation Initiative, a private public initiative with the FDA. Soo received her B.A. and M.S. from George Washington University and completed her administrative fellowship at Johns Hopkins Health System. Soo is a certified Alliance Management Professional and has a green belt in Lean Six Sigma. Soo has been a passionate partner with several Patient Advocacy groups in brain tumor research groups, LLS and PanCAN. She is also actively involved in the career development of others by leading mentorship programs within Celgene, Society of Neuro-Oncology Women & Diversity Committee, Women Leaders in Oncology at ASCO and the Healthcare Businesswomen’s Association.
Soo Bang, MHSA, CA-AM